These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31759961)

  • 1. Screening Heroin Smokers Attending Community Drug Clinics for Change in Lung Function: A Cohort Study.
    Nightingale R; Mortimer K; Giorgi E; Walker PP; Stolbrink M; Byrne T; Marwood K; Morrison-Griffiths S; Renwick S; Rylance J; Burhan H
    Chest; 2020 Mar; 157(3):558-565. PubMed ID: 31759961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Heroin Smokers Attending Community Drug Services for COPD.
    Burhan H; Young R; Byrne T; Peat R; Furlong J; Renwick S; Elkin T; Oelbaum S; Walker PP
    Chest; 2019 Feb; 155(2):279-287. PubMed ID: 30189189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Screening Study to Determine the Prevalence of Airway Disease in Heroin Smokers.
    Lewis-Burke N; Vlies B; Wooding O; Davies L; Walker PP
    COPD; 2016 Jun; 13(3):333-8. PubMed ID: 26701201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of marijuana smoking on lung function in older people.
    Tan WC; Bourbeau J; Aaron SD; Hogg JC; Maltais F; Hernandez P; Marciniuk DD; Chapman KR; To T; FitzGerald JM; Walker BL; Road J; Zheng L; Zhou G; Yau T; Benedetti A; O'Donnell D; Sin DD; ;
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31537703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry.
    Ritchie AI; Donaldson GC; Hoffman EA; Allinson JP; Bloom CI; Bolton CE; Choudhury G; Gerard SE; Guo J; Alves-Moreira L; McGarvey L; Sapey E; Stockley RA; Yip KP; Singh D; Wilkinson T; Fageras M; Ostridge K; Jöns O; Bucchioni E; Compton CH; Jones P; Mezzi K; Vestbo J; Calverley PMA; Wedzicha JA;
    Am J Respir Crit Care Med; 2024 May; 209(10):1208-1218. PubMed ID: 38175920
    [No Abstract]   [Full Text] [Related]  

  • 9. Opportunistic screening for COPD in primary care: a pooled analysis of 6,710 symptomatic smokers and ex-smokers.
    Katsimigas A; Tupper OD; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1633-1638. PubMed ID: 31413558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital readmissions with exacerbation of obstructive pulmonary disease in illicit drug smokers.
    Yadavilli R; Collins A; Ding WY; Garner N; Williams J; Burhan H
    Lung; 2014 Oct; 192(5):669-73. PubMed ID: 25097097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-Year Follow-Up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study.
    Ragland MF; Strand M; Baraghoshi D; Young KA; Kinney GL; Austin E; Hokanson JE; Regan E; Crapo J; Silverman EK; Make B
    Ann Am Thorac Soc; 2022 Mar; 19(3):381-388. PubMed ID: 34461026
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive airway disease in 46-65-year-old people in Busselton, Western Australia, 1966-2015.
    Musk AB; Hunter M; Hui J; Knuiman MW; Divitini M; Beilby JP; James A
    Med J Aust; 2018 Mar; 208(5):209-213. PubMed ID: 29540142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.
    Woodruff PG; Barr RG; Bleecker E; Christenson SA; Couper D; Curtis JL; Gouskova NA; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Lazarus SC; Martinez FJ; Paine R; Rennard S; Tashkin DP; Han MK;
    N Engl J Med; 2016 May; 374(19):1811-21. PubMed ID: 27168432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.
    Abramson MJ; Kaushik S; Benke GP; Borg BM; Smith CL; Dharmage SC; Thompson BR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1097-103. PubMed ID: 27307725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study.
    Sood A; Petersen H; Qualls C; Meek PM; Vazquez-Guillamet R; Celli BR; Tesfaigzi Y
    Respir Res; 2016 Nov; 17(1):147. PubMed ID: 27832774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.